×
Home
Archive Submission Guidelines
News Contact
Review article

Selective Immunotherapy by Engineered Chimeric Molecules

By
Nikolina Mihaylova Orcid logo ,
Nikolina Mihaylova
Andrey Tchorbanov Orcid logo
Andrey Tchorbanov

Abstract

In many physiological processes, peptides play a critical role as neurotrans mitters, hormones, antibiotics, etc. They have research importance in fields such as immunology, pharmacology, neuroscience and cell biology. There are many approaches for immunotherapies: some of them use the peptides as important components of chimeric molecules for immunosuppression, the others - as peptide-based vaccines for immunostimulation. These immunotherapeutic strategies offer the advantages of being safe, easy to produce, devoid of oncogenic potential, and can be chemically or genetically engineered into defined conformational active form. The peptides contain very important functional part called epitope, which is recognized by the immune system, specifically by antibodies, B or T cell receptors. Epitopes play a prominent role in the peptide-based vaccines and disease diagnosis. Protein-engineered or genetically engineered peptides conjugated to antibody-carrier could be used as a targeting device delivering the epitopes to the cells of interest.  

References

1.
Mackay M, Stanevsky A, Wang T, Aranow C, Li M, Koenig S, et al. Selective dys regulation of the Fc gammaIIB receptor on memory B cells in SLE. J Exp Med. 2006;203:2157–64.
2.
Kang HK, Michaels MA, Berner BR, Datta SK. Very low-dose tolerance with nucleosomal peptides controls lupus and induces potent regulatory T cell subsets. J Immunol. 2005;174(3247).
3.
Kaliyaperumal A, Michaels MA, Datta SK. Naturally processed chromatin peptides reveal a major autoepitope that primes pathogenic T and B cells of lupus. J Immunol. 2002;168(2530).
4.
Salaman MR, Mawer DPC, Hogarth MB, Seifert MH, Isenberg DA. Counter-proliferative effects of nu cleosomal antigens in cultures from lupus patients. Lupus. 2001;10(332).
5.
Tchorbanov AI, Voynova EN, Mihaylova NM, Todorov TA, Nikolova M, Yomtova VM, et al. Selective silencing of DNA-specific B lymphocytes delays lupus activity in MRL/lpr mice. Eur J Immunol. 2007;37:3587–359.

Citation

Article metrics

Google scholar: See link

The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.